Flow cytometry immunophenotyping using commercial antibodies to maximize detection of PD-1 in immuno-oncology (I-O) clinical studies with anti-PD-1 check point inhibitors (AACR 2023)
FDA Veteran Paz Vellanki, MD, joins Precision to become one of 3 ex-FDA oncology leaders supporting clients
resources center
Collected experience from groundbreaking researchers, scientists, data experts, business innovators and studies. And a convenient hub for downloading our latest service offerings from each stage of the drug development journey.
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster